Should we apply?
7 questions about Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required). The first ones are deal-breakers: grant professionals check them before writing anything. We filled in what we know. Change anything that's wrong.